Team:NYMU-Taipei/results/optomagnetic-design1
From 2011.igem.org
CHIACHENHSU (Talk | contribs) (→Whole Construct and Experimental Results) |
CHIACHENHSU (Talk | contribs) (→Whole Construct and Experimental Results) |
||
Line 43: | Line 43: | ||
==<font size=4><font color=green>Whole Construct and Experimental Results</font>== | ==<font size=4><font color=green>Whole Construct and Experimental Results</font>== | ||
- | After we have both materials of Mms13's construction and CHAMP peptides' construction, we use ligation procedure to fulfill six constructs we design in our [ | + | After we have both materials of Mms13's construction and CHAMP peptides' construction, we use ligation procedure to fulfill six constructs we design in our optomagnetic-design. |
+ | |||
+ | [[Image: c1_NYMU.png|frame|none|Fig. 3: The main design construct. Ori is the origin of replication of AMB-1. Pmsp1 is the promoter for AMB-1.]] | ||
+ | |||
+ | [[Image: c2_NYMU.png|frame|none|Fig. 4: A construct without YC on the CHAMP is our negative control in our design. It would not light up no matter there is magnetic field applied or not.]] | ||
+ | |||
+ | [[Image: c3_NYMU.png|frame|none|Fig. 5:. We design this construct with the whole YFP on the N-terminus of Mms13 and the CHAMP design to induce the BRET phenomenon. We suppose that with the CHMAP design, the construct will light up only when magnetic force is applied.]] | ||
+ | |||
+ | [[Image: c4_NYMU.png|frame|none|Fig. 6: This design is constructed with the whole YFP on the N-terminus of Mms13 but “without” the CHAMP design. The construct should be a positive control with constant light no matter whether force is applied or not.]] | ||
+ | |||
+ | [[Image: c5_NYMU.png|frame|none|Fig. 7: The design construct is similar with construct in Fig. 5. Why we construct this design with the whole YFP on the C-terminus of the CHAMP design instead of Mms13’s N-terminus is that we try to avoid the interferences of DNA transformation with sequences added in front of the natural construct. The construct is supposed to light up when force pull the Mms13 and turn off if no magnetic field is applied.]] | ||
+ | |||
+ | [[Image: c6_NYMU.png|frame|none|Fig. 8: In this last construct, only r-luciferase anchored on Mms13’s C-terminus. It will light up in yellow light (with 580 nm wavelength) due to the luciferase reaction, instead of the green light induced from BRET phenomenon (540 nm wavelength).]] | ||
+ | </font> |
Revision as of 03:19, 6 October 2011
Contents |
Constructs and Experimental Results
We now follow the steps we construct our design to examine and illustrate what we have done so far. The total parts we construct and their detailed information will be performed and recorded in our part registry.
The Beginning
As soon as we have the AMB-1 bacteria colony, we do the AMB-1 colony PCR to get the Mms13's DNA sequences as our parts to do the following steps.
The correcterized gel electrophoresis result is shown below.(See Figure 2) The detail of Mms13's information, please links to link:http://partsregistry.org/wiki/index.php?title=Part:BBa_K624005.
Construct Mms13
Then, after we have the fundamental material of Mms13, we did the next step of our construct.(See Figure 3)
The correcterized and checked results shown in Figure 4.
For parts mms13-rLuc, links to link:http://partsregistry.org/wiki/index.php?title=Part:BBa_K624007; YN-mms13-rLuc, links to link:http://partsregistry.org/wiki/index.php?title=Part:BBa_K624008; EYFP-mms13-rLuc fusion, please links to link:http://partsregistry.org/wiki/index.php?title=Part:BBa_K624006.
Construct CHAMP Design
As for the CHAMP part, we use ligation process to get the whole sequences of CHAMP peptides. However, we still use the recombinant PCR procedure to anchor either YC or YFP in our process. Several electrophoresis results for CHAMP constructs are shown below.
Whole Construct and Experimental Results
After we have both materials of Mms13's construction and CHAMP peptides' construction, we use ligation procedure to fulfill six constructs we design in our optomagnetic-design.